AGIO
Agios Pharmaceuticals, Inc.
NASDAQ · USHealthcareBiotechnology
$40.06+1.14%
Price as of Jul 20, 2026
AGIO valuation
Agios Pharmaceuticals, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 41.09x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.15x
- Price / sales
- 36.07x
- Price / cash flow
- -6.26x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 25.45x
- EV / EBITDA
- -4.02x
- EV / EBIT
- -3.54x
- Market cap
- $2.4B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.